Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joon Ho Moon

Showing results (191-200 of 280) with videos related to

Pageof 28
Sort By:
Investigational New Drugs|August 17, 2011
Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancerByung Woog Kang, Jong Gwang Kim, Yee Soo Chae, et al.
Diabetes|December 7, 2019
Serotonin Regulates Adult β-Cell Mass by Stimulating Perinatal β-Cell ProliferationJoon Ho Moon, Yeong Gi Kim, Kyuho Kim, et al.
The Korean Journal of Internal Medicine|June 19, 2023
Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II studyDong Won Baek, Han-Seung Park, Sang Kyun Sohn, et al.
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|July 1, 2006
[Association of hepatic iron deposition and serum iron indices with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease]Joon Ho Moon, Sang Hoon Park, Kil Chan Oh, et al.
British Journal of Haematology|October 26, 2013
Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotypeHangseok Choi, Chulwon Jung, Sang Kyun Sohn, et al.
Yonsei Medical Journal|May 30, 2020
Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic LeukemiaSeung Shin Lee, Sung Hoon Jung, Young Rok Do, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 3, 2017
Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" StudyJae-Ki Choi, Sung-Yeon Cho, Sung-Soo Yoon, et al.
Annals of Hematology|January 13, 2016
Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective studyJin Seok Kim, Dok Hyun Yoon, Seonyang Park, et al.
Oncotarget|November 8, 2017
Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS Working PartyDa Jung Kim, Ho Sup Lee, Joon-Ho Moon, et al.
Bone Marrow Transplantation|July 31, 2019
Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myelomaYoo Jin Lee, Joon Ho Moon, Sang Kyun Sohn, et al.
Pageof 28

Showing results (191-200 of 280) with videos related to

Sort By:
Pageof 28
Investigational New Drugs|August 17, 2011
Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancerByung Woog Kang, Jong Gwang Kim, Yee Soo Chae, et al.
Diabetes|December 7, 2019
Serotonin Regulates Adult β-Cell Mass by Stimulating Perinatal β-Cell ProliferationJoon Ho Moon, Yeong Gi Kim, Kyuho Kim, et al.
The Korean Journal of Internal Medicine|June 19, 2023
Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II studyDong Won Baek, Han-Seung Park, Sang Kyun Sohn, et al.
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|July 1, 2006
[Association of hepatic iron deposition and serum iron indices with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease]Joon Ho Moon, Sang Hoon Park, Kil Chan Oh, et al.
British Journal of Haematology|October 26, 2013
Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotypeHangseok Choi, Chulwon Jung, Sang Kyun Sohn, et al.
Yonsei Medical Journal|May 30, 2020
Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic LeukemiaSeung Shin Lee, Sung Hoon Jung, Young Rok Do, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 3, 2017
Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" StudyJae-Ki Choi, Sung-Yeon Cho, Sung-Soo Yoon, et al.
Annals of Hematology|January 13, 2016
Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective studyJin Seok Kim, Dok Hyun Yoon, Seonyang Park, et al.
Oncotarget|November 8, 2017
Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS Working PartyDa Jung Kim, Ho Sup Lee, Joon-Ho Moon, et al.
Bone Marrow Transplantation|July 31, 2019
Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myelomaYoo Jin Lee, Joon Ho Moon, Sang Kyun Sohn, et al.
Pageof 28